Peptone

Peptone is a biotechnology company that develops novel small-molecule therapeutics specifically designed to target intrinsically disordered proteins (IDPs). The company utilizes a technology stack combining next-generation machine learning, bespoke mass spectrometry, and laboratory expertise to model protein disorder and identify druggable pockets. Their platform serves the pharmaceutical industry by addressing disease-related proteins that were previously considered difficult to target due to their structural complexity.